| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.00B | +21.9% |
| Cost of Revenue | $259.2M | +22.8% |
| Gross Profit | $742.1M | +21.6% |
| R&D Expense | $323.9M | +21.3% |
| SG&A Expense | $202.1M | +9.0% |
| Operating Income | -$321.3M | +2.4% |
| Pre-tax Income | -$279.7M | +0.7% |
| Income Tax | $171.0M | +2402.5% |
| Net Income | -$450.7M | -56.3% |
| EPS (Basic) | -$1.37 | -48.9% |
| EPS (Diluted) | -$1.37 | -48.9% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $169.6M | -9.1% |
| Short-term Investments | $459.0M | -14.3% |
| Accounts Receivable | $289.1M | +22.5% |
| Current Assets | $1.05B | -1.8% |
| Total Assets | $2.44B | +1.3% |
| Current Liabilities | $756.4M | +23.3% |
| Total Liabilities | $1.00B | +35.7% |
| Stockholders' Equity |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $76.6M | +127.2% |
| Capital Expenditures | $713K | -61.7% |
| Investing Cash Flow | $87.0M | +139.8% |
| Financing Cash Flow | -$160.8M | -387.6% |
| Free Cash Flow | $75.9M | +138.2% |
| $1.44B |
| -13.9% |